Clinical Review

2014 Update on sexual dysfunction

Author and Disclosure Information

 

CASE RESOLVED After a discussion of her options, the patient chooses to stick with Brisdelle and use behavioral therapy alone to resolve her dyspareunia. At her follow-up visit 2 weeks later, she reports that she has enjoyed the period of pain-free “sex” and feels ready to add penetration into her activities.

You encourage her to continue sexual intercourse on a regular, relatively frequent basis to prevent a recurrence of dyspareunia. She continues to use silicone-based lubricants.

Share your thoughts on this article! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Pages

Recommended Reading

Hormone therapy for menopausal vasomotor symptoms
MDedge ObGyn
Enigmatic inconsistencies between WHI data and conclusions; Exaggerated or intentionally fabricated data?
MDedge ObGyn
Denosumab's benefits persist through 8 years
MDedge ObGyn
More than half of older women have experienced incontinence
MDedge ObGyn
New agent builds bone bigger, faster
MDedge ObGyn
Early low-dose menopausal hormone therapy did not affect atherosclerosis
MDedge ObGyn
Laparoscopic myomectomy with enclosed transvaginal tissue extraction
MDedge ObGyn
Vaginal bowel control device shown safe, effective in pivotal trial
MDedge ObGyn
Laparoscopic dual-port contained power morcellation: An offered solution
MDedge ObGyn
Estrogen does not cause breast cancer
MDedge ObGyn

Related Articles